Article
The M4 transmembrane segment contributes to agonist efficacy differences between alpha1 and alpha3 glycine receptors.
Molecular membrane biology - 1 Aug 2009
Chen Xuebin, Webb Timothy I, Lynch Joseph W
Abstract excerpt
To date there are few compounds known to pharmacologically discriminate between alpha1 and alpha3 subunit-containing glycine receptors (GlyRs). The present study stemmed from an observation that the glycinergic agonists, taurine and beta-alanine, act with much lower agonist efficacy at alpha3 GlyRs than at alpha1 GlyRs. We sought to understand the structural basis of this difference to provide insights relevant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
